On 4 September, Health Canada recalled two kohl eye cosmetics for lead: one of them was already found at 58,600 times the same safety limit by US health officials seven years earlier, under the identical brand name

A recall Health Canada has, in effect, made before

Kohl, also sold as kajal or surma, is a dark powder traditionally applied to the eyes across Middle Eastern, South Asian and North African communities, for cosmetic, medicinal and religious reasons alike, including on infants. Some traditional recipes make it by grinding galena, a lead sulfide ore, into powder, which is precisely why it keeps failing heavy-metal testing decades after regulators first flagged the category. Health Canada's 4 September notice does not describe a new kind of hazard. It describes a hazard the department named by product category in 2005, tested and warned about again through subsequent decades, and is now finding, once more, in two specific branded products sold through a single Toronto-area retailer between January and August 2026. The recall itself is narrow: stop using the product, return it to Sara Islamic Store for a refund. What is not narrow is how long the underlying pattern, a product marketed as an herbal or traditional eye cosmetic that turns out to carry lead well past any impurity threshold, has been on Health Canada's own record.

The numbers behind 4 September

One number is the reference threshold both regulators use. One is how far past it the identical product was measured. The third is how long Health Canada has been publicly warning about this exact product category.

The real subject: a product record that never crossed a border

Most coverage of a lead-in-cosmetics recall reads it as a quality-control failure: a supplier let an impurity through, a batch tested badly, the manufacturer needs tighter sourcing. That framing fits accidental contamination. It does not fit a kohl formulated from ground galena, where the lead is not an impurity that slipped past screening, it is the pigment the recipe calls for, which is exactly why Health Canada bans lead and its compounds outright as a cosmetic ingredient on its Cosmetic Ingredient Hotlist, a stricter rule than the 10 ppm impurity guidance the 4 September recall notice cites. Calling this an impurity violation is technically the language the recall used, but it understates what compliance would actually require: not better manufacturing, a different product. The second gap is where the same recall becomes a data problem rather than a chemistry problem. Al-Asmad Alharmain Zam Zam & Rose Water did not need to be discovered in 2026. It was discovered, by name, at 59 percent lead, by public health officials across the border in 2019. Nothing about that 2019 finding attached itself to the product when it later entered the Canadian market under the identical brand name; it took a fresh, unconnected Canadian testing effort, and 576 units already sold, to reach the same conclusion a different country's health department had already published seven years earlier. A hazard finding on a named product, in any market, is durable information. Whether it travels to the next market that product enters is a data and process question, not a chemistry one, and on this evidence the answer was no.

Why it matters for brands

The direct exposure sits with retailers, marketplaces and specialty grocers expanding their assortment into traditional, cultural or religious personal-care goods, a real growth category for multi-category platforms serving diaspora communities. Labeling a product 'herbal,' 'natural' or 'traditional' changes nothing about which regulatory regime applies: once an item is a cosmetic under the Food and Drugs Act, Canada's heavy-metal impurity guidance and its outright ban on lead as an ingredient apply exactly as they would to a mainstream eyeliner, and a recipe rooted in centuries of tradition is not a compliance exemption. The more durable lesson is about product history, not product chemistry. A brand name that has already failed a public health test in one country is a checkable fact before it is listed in another, not something a buyer discovers only after a local recall. Any retailer sourcing traditional or imported personal-care items, directly or through a network of small suppliers, gains more from screening incoming SKUs against prior international recalls and public health findings under the same product and brand name than from testing each shipment in isolation and hoping the last market's findings do not repeat. The channel this recall moved through, a single storefront selling under 600 units of each item over eight months, is itself a signal worth building into that screening: low-volume, single-location import routes are exactly where a previously flagged product is most likely to resurface unnoticed.

Two ways to read 4 September

Frequently asked questions